SEARCH

SEARCH BY CITATION

References

  • 1
    Feldman EC, Mack RE. Urine cortisol:creatinine ratio as a screening test for hyperadrenocorticism in dogs. J Am Vet Med Assoc 1992;200:16371641.
  • 2
    Jensen AL, Iversen L, Koch J, et al. Evaluation of the urinary cortisol:creatinine ratio in the diagnosis of hyperadrenocorticism in dogs. J Small Anim Pract 1997;38:99102.
  • 3
    Smiley LE, Peterson ME. Evaluation of a urine cortisol:creatinine ratio as a screening test for hyperadrenocorticism in dogs. J Vet Intern Med 1993;7:163168.
  • 4
    Stolp R, Rijnberk A, Meijer JC, et al. Urinary corticoids in the diagnosis of canine hyperadrenocorticism. Res Vet Sci 1983;34:141144.
  • 5
    Kaplan AJ, Peterson ME, Kemppainen RJ. Effects of disease on the results of diagnostic tests for use in detecting hyperadrenocorticism in dogs. J Am Vet Med Assoc 1995;207:445451.
  • 6
    Rijnberk A, van Wees A, Mol JA. Assessment of two tests for the diagnosis of canine hyperadrenocorticism. Vet Rec 1988;122:178180.
  • 7
    van Vonderen IK, Kooistra HS, Rijnberk A. Influence of veterinary care on the urinary corticoid:creatinine ratio in dogs. J Vet Intern Med 1998;12:431435.
  • 8
    Feldman EC, Nelson RW. Canine hyperadrenocorticism. In: Feldman EC, Nelson RW, eds. Canine and Feline Endocrinology and Reproduction, 3rd ed. St. Louis, MO: Saunders; 2004:302303.
  • 9
    Horie H, Kidowaki T, Koyama Y, et al. Specificity assessment of immunoassay kits for determination of urinary free cortisol concentrations. Clinica Chim Acta 2007;378:6670.
  • 10
    Murphy BE, Okouneff LM, Klein GP, et al. Lack of specificity of cortisol determinations in human urine. J Clin Endocrinol Metab 1981;53:9199.
  • 11
    Pearson Murphy BE. Lack of specificity of urinary free cortisol determinations: Why does it continue? J Clin Endocrinol Metab 1999;84:22582259.
  • 12
    Schoneshofer M, Fenner A, Dulce HJ. Interferences in the radioimmunological determination of urinary free cortisol. Clinica Chim Acta 1980;101:125134.
  • 13
    Zeugswetter FK, Neffe F, Schwendenwein I, et al. Configuration of antibodies for assay of urinary cortisol in dogs influences analytic specificity. Domest Anim Endocrinol 2013;45:98104.
  • 14
    Herrtage ME, Ramsey IK. Canine hyperadrenocorticism. In: Mooney CT, Peterson ME, eds. BSVA Manual of Canine and Feline Endocrinology, 4th ed. Gloucester, GB: British Small Animal Veterinary Association; 2011:167189.
  • 15
    Fong BM, Tam S, Leung KS. Improved liquid chromatography-tandem mass spectrometry method in clinical utility for the diagnosis of Cushing's syndrome. Anal Bioanal Chem 2010;396:783790.
  • 16
    Siekmann L. Determination of steroid hormones by the use of isotope dilution–mass spectrometry: A definitive method in clinical chemistry. J Steroid Biochem 1979;11:117123.
  • 17
    Wood L, Ducroq DH, Fraser HL, et al. Measurement of urinary free cortisol by tandem mass spectrometry and comparison with results obtained by gas chromatography-mass spectrometry and two commercial immunoassays. Ann Clin Biochem 2008;45:380388.
  • 18
    Burkhardt WA, Boretti FS, Reusch CE, et al. Evaluation of baseline cortisol, endogenous ACTH, and cortisol/ACTH ratio to monitor trilostane treatment in dogs with pituitary-dependent hypercortisolism. J Vet Intern Med 2013;27:919923.
  • 19
    Quante S, Boretti FS, Kook PH, et al. Urinary catecholamine and metanephrine to creatinine ratios in dogs with hyperadrenocorticism or pheochromocytoma, and in healthy dogs. J Vet Intern Med 2010;24:10931097.
  • 20
    Sieber-Ruckstuhl NS, Boretti FS, Wenger M, et al. Serum concentrations of cortisol and cortisone in healthy dogs and dogs with pituitary-dependent hyperadrenocorticism treated with trilostane. Vet Rec 2008;163:477481.
  • 21
    Ruckstuhl NS, Nett CS, Reusch CE. Results of clinical examinations, laboratory tests, and ultrasonography in dogs with pituitary-dependent hyperadrenocorticism treated with trilostane. Am J Vet Res 2002;63:506512.
  • 22
    Bablok W, Passing H. Application of statistical procedures in analytical instrument testing. J Automat Chem 1985;7:7479.
  • 23
    Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307310.
  • 24
    Zeugswetter F, Bydzovsky N, Kampner D, et al. Tailored reference limits for urine corticoid:creatinine ratio in dogs to answer distinct clinical questions. Vet Rec 2010;167:9971001.
  • 25
    Gray G, Shakerdi L, Wallace AM. Poor specificity and recovery of urinary free cortisol as determined by the Bayer ADVIA Centaur extraction method. Ann Clin Biochem 2003;40:563565.
  • 26
    McCann SJ, Gillingwater S, Keevil BG. Measurement of urinary free cortisol using liquid chromatography-tandem mass spectrometry: Comparison with the urine adapted ACS:180 serum cortisol chemiluminescent immunoassay and development of a new reference range. Ann Clin Biochem 2005;42:112118.
  • 27
    Holder G. External quality assessment of urinary-free cortisol measurement in the UK against a gas chromatography mass spectroscopy reference method. Ann Clin Biochem 1995;32:8490.
  • 28
    Lee C. 6 beta-hydroxycortisol interferes with immunoassay of urinary free cortisol. Clin Chem 1996;42:12901291.
  • 29
    Kennedy DM, Selby C, Lawson N. Measurement of urinary free cortisol using the Acs:180 serum cortisol chemiluminescent immunoassay. Ann Clin Biochem 2000;37(Pt 4):520528.
  • 30
    Behrend EN, Kooistra HS, Nelson R, et al. Diagnosis of spontaneous canine hyperadrenocorticism: 2012 ACVIM consensus statement (small animal). J Vet Intern Med 2013;27:12921304.
  • 31
    Cerundolo R, Lloyd DH, Vaessen MM, et al. Alopecia in Pomeranians and Miniature Poodles in association with high urinary corticoid:creatinine ratios and resistance to glucocorticoid feedback. Vet Rec 2007;160:393397.
  • 32
    Galac SR, Reusch CE, Kooistra HS, Rijnberk A. Adrenals: Glucocorticoid excess. In: Rijnberk A, Kooistra HS, eds. Clinical Endocrinology of Dogs and Cats, 2nd ed. Hannover: Schlütersche Verlagsgesellschaft mbH & Co KG; 2010:116.